Current Funding:

“Biophysical constraints on evolution of enzyme specificity” National Institutes of Health (NIH), R01 GM124409, PI: M. Glasner, Co-PIs: Romo and Hull, Aug. 2018-April 2022

Completed Funding:

“Recruitment of established investigators CPRIT Scholar Award” The Cancer Prevention and Research Institute of Texas, R1309, PI: John Wood, 2013-2019

“Hookworm Metabolome and Therapeutic Development” Collaborative Faculty Research Investment Program (CFRIP) Award of Baylor University, Baylor Scott & White Health and Baylor College of Medicine, Co-PI: Daniel Romo, June 2017-May 2018

“Mode of Action of the Amaryllidaceae Alkaloid Lycorine-Promising Anticancer Agent” National Institutes of Health (NCI),  R15CA186046, PI: Alexander Kornienko, Co-PIs: Ken Hull and Daniel Romo, July 2014-June 2017.

“Creating Novel Translation Inhibitors to Target Pro-survival Oncoproteins” Cancer Prevention and Research Institute of Texas, RP130660, PI: Daniel Romo Co-PI: William K. Plunkett, Jan. 2014-May 2015.

“Structure-Activity Relationship Studies and Cellular Probe Synthesis of Marine Natural Products Targeting Novel Modes of Action for Human Disease” Texas A&M University- National Science Foundation China (NSFC) Collaborative Research Program, 2014-039, PI: Daniel Romo PI: Wenhan Lin, Sept. 2014-Aug. 2015.